CVS CVS Stock Price Quote NYSE:CVS
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers. Sign up for a Robinhood brokerage account to buy or sell CVS Health Corp. stock and options commission-free.
D-RATED STOCKS are those stocks our Big Data multi-factor models score as moderately probable to fall in price. While these stocks score as UNATTRACTIVE, we believe the best shorts are our TOP SHORTS which are F-rated stocks.
Here are our analysts’ top ideas in each sector for the new year. The narrow-moat company beat our expectations, and we are keeping our fair value estimate at $92 per share. Here https://dotbig.com/markets/stocks/CVS/ are our analysts’ top ideas in each sector for the coming quarter. However, investors may be disappointed that CVS backed off its 2022 goal of double-digit earnings growth.
Is It Time to Sell CVS? Shares are up today.
Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. Based on this pricing period, the resulting amount of cash received for each AdvancePCS share held was $7.01. Each holder of Aetna common stock will receive a letter of transmittal with instructions explaining how to exchange shares of Aetna common stock for shares https://dotbig.com/markets/stocks/CVS/ of CVS Health common stock. For the cash portion of the consideration, payment will be deposited or made available within two days of the close of the transaction. For holders of certificates, the merger consideration will be paid only after surrender of your Aetna certificates as described in the letter of transmittal. If you cannot locate your Aetna stock certificates, the letter of transmittal will provide instructions on what to do.
An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. Higher On Q3 Earnings Beat, Profit Outlook Boost, $5 Billion Opioid SettlementHealthcare benefits sales continued to power both the top and bottom line for CVS, which boosted its full-year profit forecast for the third consecutive quarter.
Top 10 Holdings of Our Ultimate Stock-Pickers’ Index
CVS Health has 16.16% upside potential, based on the analysts’ average price target. The highest, average, and lowest price target of all analysts. Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. F-RATED STOCKS are those stocks our quantitative multi-factor models score as most probable to fall in price. A-RATED DotBig STOCKS are those stocks the Big Data multi-factor models score as most probable to rise in price. Direct Registration is a service within the securities industry that allows shares to be owned and tracked electronically without having a stock certificate issued. For more information about Direct Registration, call EQ Shareowner Services toll-free at CVS-PLAN.
- 129 people have searched for CVS on MarketBeat in the last 30 days.
- Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes.
- CVS’s price can fluctuate throughout the course of each trading day—when you buy CVS through Stash, we execute the market order during our next available trading window .
- The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Retail clinic services", "Physical retail of pharmaceuticals at a pharmacy", and "Physical retail of dental health products at a pharmacy" products.
It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction. The stock responded well to third-quarter earnings, but the company also lost a frightening $3.4 billion DotBig in the third quarter. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023. The U.S. MUST find NEW domestic sources of critical minerals, such as cobalt, lithium and rare earths needed to ensure superiority in our military and mobile and green technologies.
PFE, JNJ, or CVS: Which Healthcare Stock is a “Strong Buy” for Wall Street Pros?
If you held your shares of Omnicare common stock in certificated form, you were sent a letter of transmittal promptly after the completion of the merger, describing how you may exchange your shares of company common stock for the DotBig merger consideration. If you were not required by the paying agent to deliver an executed letter of transmittal, you received payment for the merger consideration from the paying agent without any further action on your part.
One exploration company is determined to help with potential big discoveries in Idaho, Montana and Nevada. Sign-up to receive the latest news and ratings for CVS Health and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of CVS Health is 43.26, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 36.61. 77.64% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
According to analysts’ consensus price target of $118.68, CVS Health has a forecasted upside of 16.8% from its current price of $101.65. CVS Health released its earnings results on Nov 02, 2022. The company reported $2.09 earnings per share for the quarter, beating the CVS stock consensus estimate of $1.996 by $0.094. Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
Such data, information, or opinions are not an offer to sell or to buy, or a solicitation to buy or sell any securities. All investments and investment recommendations entail risks. Any forward looking estimates presented by Quantalytics may prove to be incorrect and not be realized. Any data, information, or opinions expressed in any form may change without notice. The data, information and opinions presented have been CVS stock obtained or derived from sources believed by Quantalytics to be reliable. Quantalytics does not make any representations as to their accuracy or completeness. Nothing discussed or presented in Quantalytics constitutes a representation that any investment, investment strategy, or recommendation is suitable or appropriate to an investor’s individual circumstances or otherwise constitutes a personal recommendation.
Analyst Rating Consensus
Quantalytics is not a registered investment adviser, brokerage firm, or investment company. Any data, https://dotbig.com/ information, or opinions presented by Quantalytics are for general information purposes only.